Joint 1994 Wolff Award Presentation. Peripheral and central trigeminovascular activation in cat is blocked by the serotonin (5HT)-1D receptor agonist 311C90.
about
Tonabersat (SB-220453) a novel benzopyran with anticonvulsant properties attenuates trigeminal nerve-induced neurovascular reflexesCurrent and emerging second-generation triptans in acute migraine therapy: a comparative review.A translational in vivo model of trigeminal autonomic cephalalgias: therapeutic characterization.Effects of a selective 5-HT(1B/1D) receptor agonist on spinal and trigeminal reflexes in the anaesthetized rabbit.'Side locked' migraine and trigeminal autonomic cephalgias: evidence for clinical overlap.Blockade of CGRP receptors in the intracranial vasculature: a new target in the treatment of headache.Can we develop neurally acting drugs for the treatment of migraine?Zolmitriptan intranasal: a review of the pharmacokinetics and clinical efficacy.Migraine: emerging treatment options for preventive and acute attack therapy.The blood-brain barrier in migraine treatment.CGRP receptor antagonism and migraine.The extracranial vascular theory of migraine: an artificial controversy.The biological basis of headache.Antidromic vasodilatation and the migraine mechanism.The Journey to Establish CGRP as a Migraine Target: A Retrospective View.Fremanezumab as Add-On Treatment for Patients Treated With Other Migraine Preventive Medicines.Autoradiographic Mapping of 5-HT(1B/1D) Binding Sites in the Rhesus Monkey Brain Using [carbonyl-C]zolmitriptan.Diverse Physiological Roles of Calcitonin Gene-Related Peptide in Migraine Pathology: Modulation of Neuronal-Glial-Immune Cells to Promote Peripheral and Central Sensitization.Pathophysiology of Migraine: A Disorder of Sensory Processing.Pre-clinical pharmacology of zolmitriptan (Zomig; formerly 311C90), a centrally and peripherally acting 5HT1B/1D agonist for migraine.Calcitonin gene-related peptide (CGRP) modulates nociceptive trigeminovascular transmission in the cat.Trigeminal nerve ganglion stimulation-induced neurovascular reflexes in the anaesthetized cat: role of endothelin(B) receptors in carotid vasodilatation.Blocking CGRP in migraine patients - a review of pros and cons.5HT1B/1D agonists.Randomized, double-blind, placebo-controlled, proof-of-concept study of the cortical spreading depression inhibiting agent tonabersat in migraine prophylaxis.Selective Inhibition of Trigeminovascular Neurons by Fremanezumab: A Humanized Monoclonal Anti-CGRP Antibody.Multiple attack study on the available triptans in Italy versus placebo.Intensity dependence of the cortical auditory evoked potentials as a surrogate marker of central nervous system serotonin transmission in man: demonstration of a central effect for the 5HT1B/1D agonist zolmitriptan (311C90, Zomig).Convergence of occipital nerve and superior sagittal sinus input in the cervical spinal cord of the cat.Direct evidence for central sites of action of zolmitriptan (311C90): an autoradiographic study in cat.A Comparative Study of Orally Delivered PBCA and ApoE Coupled BSA Nanoparticles for Brain Targeting of Sumatriptan Succinate in Therapeutic Management of Migraine.Distribution of [3H]-sumatriptan binding sites in human brain.PACAP and its role in primary headaches.Migraine-like accompanying features in patients with cluster headache. How important are they?311C90 (Zolmitriptan), a novel centrally and peripheral acting oral 5-hydroxytryptamine-1D agonist: a comparison of its absorption during a migraine attack and in a migraine-free period.The clinical pharmacokinetics of zolmitriptan.Comparison of the Efficacy of Zolmitriptan and Sumatriptan: Issues in Migraine Trial DesignEffects of Zolmitriptan (ZomigTM) on Central Serotonergic Neurotransmission as Assessed by Active Oddball Auditory Event-Related Potentials in Volunteers without Migraine
P2860
Q28361230-C2AC08A9-0BB1-4A09-91FE-FF87231E0753Q33908453-6905FD41-E3BC-4FC9-B64B-1DBF69CF1E67Q34445305-CBCF3F61-7BEB-4965-BC4F-91F988879835Q35042847-40517052-7662-4B36-AD31-C95A5975DAB8Q35048155-98E37427-D600-4FAA-B9ED-A47CCCBA483CQ35841612-44B78131-5C49-41FC-9F3E-CDCE9BBBCA3AQ36240187-33F08A37-E4B3-4FBD-BE2C-C95B41D143EDQ36367884-212C149D-5A30-46F1-9E70-BD648B65F819Q36580576-62A83E24-5B59-4C04-9436-B84551E9D5DDQ37252452-B9598971-352E-4AAA-8160-9AFBA1A0C040Q37374122-7B83C88F-1C41-498E-942D-F4DFD5A18592Q37826098-24440F60-7755-44D8-991D-FCFFC19F4D4AQ37849764-29E9A27D-F725-4C56-823E-4E6D985B1321Q37971447-0D794D86-9B63-460C-A2F8-597F095FA3C2Q38561443-383DEAC0-BE3A-4B99-AF7C-2DD77873D7FFQ38598006-2AC13FF6-D897-4EC8-90C1-6C53D0CF64AEQ38733029-FB4A8B17-E9F3-405F-A1D1-26E27D01CE39Q38873658-6186FB4B-E30C-4BF7-BE4E-CB92611E4768Q39127073-7F25902F-4BE0-42AF-8596-B4C2F144F05FQ41661654-FADD4680-A5A3-4248-AA4A-F9599C1C8741Q41974492-F81951D9-FB41-4B69-B015-2282533E961CQ42116885-18D4DA38-4F2A-46A5-80BD-0F9D93D8B321Q42363673-436E50F1-DB1F-4F65-B33F-989182CC4995Q44202492-9B060538-513B-4E2E-9CFD-230709BBD0AEQ46119680-5C0AB380-8D0D-45CA-98CF-EFE47A9A409BQ46200045-C593CAD0-19F8-4220-BFEF-935FF148C88EQ46548647-E341E1C1-0500-442E-A650-426A85D9CDE3Q48547455-DC10C5C0-D5C9-4881-A7EA-DE9A6553C697Q48604092-FA22CE5E-6ECA-48B3-AB22-AE1002FBBD5DQ48715691-F864AD3F-10A8-48DC-AEF1-DDF9AC7079E8Q48818624-F481F81C-E02E-4E79-A117-86C8F92F5A2EQ48949918-E299C4F2-5A3A-4B43-B118-2E6692155FD8Q52360955-06E1F1BF-BD4D-4768-B696-EEABA6611461Q53113336-CF97BEE3-1C1D-4E55-B797-422178FE1352Q53986729-1C7112EB-D88E-4253-BBE1-1356495794EAQ54394241-8D541F0A-67A2-4ED4-991F-F3205C248BCBQ57024741-F1D8AFCD-3FBB-4E4B-A6EC-D59BBF0FE647Q59305050-05655292-1CEF-4E92-9996-7B8FF5225857
P2860
Joint 1994 Wolff Award Presentation. Peripheral and central trigeminovascular activation in cat is blocked by the serotonin (5HT)-1D receptor agonist 311C90.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Joint 1994 Wolff Award Present ...... T)-1D receptor agonist 311C90.
@ast
Joint 1994 Wolff Award Present ...... T)-1D receptor agonist 311C90.
@en
type
label
Joint 1994 Wolff Award Present ...... T)-1D receptor agonist 311C90.
@ast
Joint 1994 Wolff Award Present ...... T)-1D receptor agonist 311C90.
@en
prefLabel
Joint 1994 Wolff Award Present ...... T)-1D receptor agonist 311C90.
@ast
Joint 1994 Wolff Award Present ...... T)-1D receptor agonist 311C90.
@en
P1433
P1476
Joint 1994 Wolff Award Present ...... T)-1D receptor agonist 311C90.
@en
P2093
Goadsby PJ
P304
P356
10.1111/J.1526-4610.1994.HED3407394.X
P577
1994-07-01T00:00:00Z